Heier Jeffrey S.
Chief Scientific Officer
Heier Jeffrey S. has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, Heier Jeffrey S. is listed as Chief Scientific Officer at OCULAR THERAPEUTIX, INC. Inside the rolling window, Heier Jeffrey S. reported no open-market purchases and 5 open-market sales totaling $204K in OCUL. The largest disclosed transaction in the window is a sale of 10,869 OCUL shares on Oct 2, 2026, worth $77K.
Companies traded
Other insiders at OCUL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$204K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 2, 2025 | OCUL | Sale | $116K |
Frequently asked questions
How many SEC Form 4 filings has Heier Jeffrey S. made?
Heier Jeffrey S. has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Heier Jeffrey S. trade?
Heier Jeffrey S. has filed SEC Form 4 disclosures for 1 company, including OCUL.
When was Heier Jeffrey S.'s most recent SEC Form 4 filing?
Heier Jeffrey S.'s most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is Heier Jeffrey S.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Heier Jeffrey S. is listed as Chief Scientific Officer.
What is Heier Jeffrey S.'s total buy and sell value in the current window?
Inside the rolling retention window, Heier Jeffrey S. bought $0 and sold $204K based on SEC Form 4 filings.
What was Heier Jeffrey S.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,869 OCUL shares on 2026-10-02, worth $77K, per SEC Form 4 filings.